Avoid alcohol, caffeine in excess, and tobacco products, all of which dry out oral tissues further
Its being closely monitored in advanced clinical trials for its possible enhanced effects
More recently, the SELECT trial showed that semaglutide 2.4 mg reduced major adverse cardiovascular events in adults with overweight or obesity without diabetes
Whats more, they kept the weight off six months later
Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
In a 48-week study involving adults with obesity, participants receiving the highest weekly dose achieved an average body weight reduction of up to 24.2%